SCREENING FOR BREAST CANCER IN USERS AND NON USERS OF HORMONE REPLACEMENT THERAPY (HRT)

dc.contributor.author	De zoysa, M.I.M.
dc.contributor.author	Pereral, O.J.C.
dc.contributor.author	Peiris, W.C.V.
dc.date.accessioned	2012-09-06T04:37:32Z
dc.date.available	2012-09-06T04:37:32Z
dc.date.issued	2012
dc.identifier.uri	http://archive.cmb.ac.lk:8080/xmlui/handle/70130/2902
dc.description.abstract	Screening for breast cancer in patients using HRT remains a controversial issue. There is evidence lo show that in the western world daily use of combined HRT increases a woman's chance of developing breast cancer by about 5% to 6% with each year of use. The objective of this study was to compare the incidence of breast cancer in women taking HRT with a similar group of postmenopausal women who are not on HRT.
dc.language.iso	en	en_US
dc.title	SCREENING FOR BREAST CANCER IN USERS AND NON USERS OF HORMONE REPLACEMENT THERAPY (HRT)	en_US
dc.type	Research abstract	en_US